Are people who use “natural drugs” aware of their potentially harmful side effects and reporting to family physician?

Giveon, Shmuel; Liberman, Nicky; Klang, Shmuel; Kahan, Ernesto

doi:10.1016/s0738-3991(03)00241-6

Cited by 95 publications

(91 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Of these 129 CAM therapies, only 28% were recorded in the patients' charts (Cockayne, Duguid, & Shenfield, 2005). Giveon, Liberman, Klang, & Kahan (2004) state that among CAM users close to 40% of them never reported their use to their physicians. In a comprehensive literature search, the proportion of CAM users not reporting their use was as high as 77% (Robinson & McGrail, 2004 same study revealed that the top reasons for not disclosing use were expectation of a negative reaction from their health care provider, the thought that there was no need to report CAM use, and the fact that they were never asked about CAM by their health care provider (Robinson & McGrail, 2004).…”

Section: Patient Underreporting Of Cam Use To Health Care Providersmentioning

confidence: 99%

Uninformed Complementary and Alternative Supplement Use: A Risky Behavior for Cardiovascular Patients

Bristol

Sonnad

Guerra

2008

Complementary health practice review

View full text Add to dashboard Cite

Growing use of complementary and alternative supplements (CAS) is of concern because of the potential for herb-drug interaction among cardiovascular patients. Literary searches were conducted on PubMed to identify reports of extent and purpose of CAS use, disclosure of use by patients, physician knowledge, and possible drug-CAS interactions for cardiovascular patients. Additional published studies were located through the Web sites of various organizations. Further searches of case reports, case series, controlled trials, and laboratory evidence were performed for each of the top 10 CAS and their possible cardiovascular drug interactions. More research is needed to understand supplement-drug interactions, particularly in terms of how this potentially affects patients taking cardiovascular drugs. With this lack of research and clarity on supplement-dug interactions and the underreporting of CAS use by many patients, physician education is also in need of improvement.

show abstract

Section: Patient Underreporting Of Cam Use To Health Care Providersmentioning

confidence: 99%

Uninformed Complementary and Alternative Supplement Use: A Risky Behavior for Cardiovascular Patients

Bristol

Sonnad

Guerra

2008

Complementary health practice review

View full text Add to dashboard Cite

show abstract

“…A Organização Mundial da Saúde (OMS) estimou que 80% da população dependam da medicina tradicional (Springfield et al, 2005). A cultura do uso de plantas e de outras fontes naturais com propriedades terapêuticas vem sendo valorizada pela sociedade do mundo inteiro e retornou ao status de uma fonte de produtos medicinais devido à busca por hábitos mais saudáveis de vida e pelo difícil tratamento de certas doenças e resistência microbiana (De Smet, 2004;Giveon et al, 2004;Rocha et al, 2004;Bugno et al, 2005).…”

Section: Introductionunclassified

O Brasil no contexto de controle de qualidade de plantas medicinais

Souza-Moreira¹,

Salgado²,

Pietro³

2010

Rev. bras. farmacogn.

View full text Add to dashboard Cite

RESUMO:Atualmente, as plantas medicinais movem altos valores financeiros em todo o mundo e representam o tipo de tratamento mais acessível para cerca de 80% da população, principalmente entre os países em desenvolvimento. Entretanto, existe ainda uma falta de conhecimento sobre propriedades químicas, farmacológicas e toxicológicas a fim de assegurar a eficácia e segurança das plantas medicinais. Os critérios de eficácia e segurança de plantas medicinais estão relacionados a qualidade, isto é, as plantas necessitam ser corretamente identificadas, cultivadas e coletadas, devem estar livres de material estranho, partes de outras plantas e contaminações inorgânicas e/ ou microbianas. O objetivo deste estudo foi o de elucidar os diferentes processos e padronizações sobre o controle de drogas vegetais, principalmente no Brasil.Unitermos: Plantas medicinais, fitoquímica, controle de qualidade.ABSTRACT: "Brazil in the context of plants and derivates quality control". Nowadays medicinal plants move high financial values at the world and represent a type of treatment more accessible for about 80% of people, mainly among developing countries. However, there is a lack of knowledge about chemical, pharmacological and toxicological properties towards ensure their efficacy and safety. Efficacy and safety criteria of medicinal plants are related to quality, that is, the plants need to be correctly identified, cultivated and harvested, they must be free of strange material, part of other plants and inorganic and/or microorganisms contamination. The aim of this study was to elucidate different process and standardizations about quality control of vegetal drugs mainly in Brazil. ISSN 0102-695X Keywords INTRODUÇÃOPor longos períodos na história, o uso de plantas medicinais foi presente não só devido ao seu caráter alimentar, mas também às suas propriedades de cura, sejam elas reais ou ritualísticas. Entretanto, até a metade do século XX, o uso de medicamentos de origem sintética tornou-se mais amplo que o uso de plantas medicinais, principalmente na sociedade ocidental, com destaque para os países desenvolvidos visto que os considerados países em desenvolvimento permaneceram fazendo uso das propriedades curativas das plantas, certamente devido às difíceis condições econômicas de aquisição dos medicamentos sintéticos

show abstract

“…Moreover, individuals may be using CAM alongside conventional treatments and paying for their treatment. At the same time, there is a varying picture of the recognition of CAM and its beneits by medical practitioners, along with a reluctance to [37]. his co-exists with a hesitancy or avoidance by their patients to tell the medical practitioner either about their use of CAM or to ask about its possible beneits in treating the illness.…”

Section: Cam Prevalencementioning

confidence: 99%

Complementary and Alternative Medicine (CAM) and the Public Health: an Innovative Healthcare Practice in Supporting and Sustaining Health and Well-Being

Long¹

2014

Epidemiol

View full text Add to dashboard Cite

IntroductionPublic health is commonly deined as 'the science and art of preventing disease, prolonging life and promoting health through the organised eforts of society' [1]. It centres on promoting and protecting the health of communities, individual citizens and the wider population. Epidemiology with its focus on exploring and identifying the determinants of ill-health and why and how some stay healthy [2], and by extension health inequalities [3] is a core contributory discipline generating evidence on inluences, causes and potential ways to break the causal chain, thus enhancing health.In a European context where a cross-country average of 3% is spent on prevention [4] one must question why a greater proportion of healthcare expenditure is not targeted and invested 'upstream' with a view to addressing the root socio-economic and cultural causes of ill-health and health inequalities, thus, intervening with whom or whatever is 'pushing them into the river'. he diicult of such a funding and policy action is compounded by population ageing and increased survival, accompanied by an increasing burden of chronic illness and associated co-morbidity [4] all to be addressed within tight resource constraints. here remains the urgent imperative to treat and care for those 'downstream', 'pulling them out of the river'.With the publication of Health 2020 [5] and its approval by the 53 countries within the European health region at a session of the WHO Regional Committee for Europe in September 2012, a higher priority for a shit in focus and resurgence of public health arises. his policy framework aims to 'signiicantly improve the health and well-being of populations, reduce health inequalities, strengthen public health and ensure people-centred health systems. ' (ibid, p1). It identiies four priority areas for policy action, throughout emphasising 'developing assets and resilience within communities, empowerment and creating supportive environments. ' (ibid, pvi). Public health is identiied as the third priority area, drawing attention to the importance of investing in health through the life-course, in order to empower and create resilience in supportive environments. As Dr Zsuzsanna Jakab, WHO Regional Director for Europe, argued at the fourth annual conference of the [6] European Public Health Alliance (2013), 'today's health emphasis is on non-communicable diseases and mental health problems. Also important is health-related behaviour, including tobacco and alcohol use, diet and physical activity: behaviour, which is itself socially determined and oten relects the stresses and disadvantages in people's lives.' he challenge of converting this political/policy level rhetoric into implementation and practical action remains to be realised.Public health and Health 2020 (WHO 2013) draw explicit attention both to the social determinants of ill-health and the role of individuals and communities in enabling health. Associated notions include health promotion, empowerment and health literacy, all potentially aimed and taken f...

show abstract

Are people who use “natural drugs” aware of their potentially harmful side effects and reporting to family physician?

Cited by 95 publications

References 17 publications

Uninformed Complementary and Alternative Supplement Use: A Risky Behavior for Cardiovascular Patients

Uninformed Complementary and Alternative Supplement Use: A Risky Behavior for Cardiovascular Patients

O Brasil no contexto de controle de qualidade de plantas medicinais

Complementary and Alternative Medicine (CAM) and the Public Health: an Innovative Healthcare Practice in Supporting and Sustaining Health and Well-Being

Contact Info

Product

Resources

About